These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 32772265

  • 21. Antibody engagement with amyloid-beta does not inhibit [11C]PiB binding for PET imaging.
    Xiong M, Dahlén A, Roshanbin S, Wik E, Aguilar X, Eriksson J, Sehlin D, Syvänen S.
    J Neurochem; 2024 Sep; 168(9):2601-2610. PubMed ID: 38721627
    [Abstract] [Full Text] [Related]

  • 22. Characterization and first human investigation of FIBT, a novel fluorinated Aβ plaque neuroimaging PET radioligand.
    Yousefi BH, Manook A, Grimmer T, Arzberger T, von Reutern B, Henriksen G, Drzezga A, Förster S, Schwaiger M, Wester HJ.
    ACS Chem Neurosci; 2015 Mar 18; 6(3):428-37. PubMed ID: 25482310
    [Abstract] [Full Text] [Related]

  • 23. Diagnostic Accuracy of Amyloid versus 18 F-Fluorodeoxyglucose Positron Emission Tomography in Autopsy-Confirmed Dementia.
    Lesman-Segev OH, La Joie R, Iaccarino L, Lobach I, Rosen HJ, Seo SW, Janabi M, Baker SL, Edwards L, Pham J, Olichney J, Boxer A, Huang E, Gorno-Tempini M, DeCarli C, Hepker M, Hwang JL, Miller BL, Spina S, Grinberg LT, Seeley WW, Jagust WJ, Rabinovici GD.
    Ann Neurol; 2021 Feb 18; 89(2):389-401. PubMed ID: 33219525
    [Abstract] [Full Text] [Related]

  • 24. [(18)F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies.
    Rinne JO, Wong DF, Wolk DA, Leinonen V, Arnold SE, Buckley C, Smith A, McLain R, Sherwin PF, Farrar G, Kailajärvi M, Grachev ID.
    Acta Neuropathol; 2012 Dec 18; 124(6):833-45. PubMed ID: 23053137
    [Abstract] [Full Text] [Related]

  • 25. In vivo SPECT imaging of amyloid-β deposition with radioiodinated imidazo[1,2-a]pyridine derivative DRM106 in a mouse model of Alzheimer's disease.
    Chen CJ, Bando K, Ashino H, Taguchi K, Shiraishi H, Shima K, Fujimoto O, Kitamura C, Matsushima S, Uchida K, Nakahara Y, Kasahara H, Minamizawa T, Jiang C, Zhang MR, Ono M, Tokunaga M, Suhara T, Higuchi M, Yamada K, Ji B.
    J Nucl Med; 2015 Jan 18; 56(1):120-6. PubMed ID: 25476539
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The flutemetamol analogue cyano-flutemetamol detects myocardial AL and ATTR amyloid deposits: a post-mortem histofluorescence analysis.
    Abrahamson EE, Padera RF, Davies J, Farrar G, Villemagne VL, Dorbala S, Ikonomovic MD.
    Amyloid; 2023 Jun 18; 30(2):169-187. PubMed ID: 36411500
    [Abstract] [Full Text] [Related]

  • 28. Pittsburgh compound B and the postmortem diagnosis of Alzheimer disease.
    Niedowicz DM, Beckett TL, Matveev S, Weidner AM, Baig I, Kryscio RJ, Mendiondo MS, LeVine H, Keller JN, Murphy MP.
    Ann Neurol; 2012 Oct 18; 72(4):564-70. PubMed ID: 23109151
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography.
    Wolk DA, Zhang Z, Boudhar S, Clark CM, Pontecorvo MJ, Arnold SE.
    J Neurol Neurosurg Psychiatry; 2012 Sep 18; 83(9):923-6. PubMed ID: 22791901
    [Abstract] [Full Text] [Related]

  • 31. Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid.
    Vallabhajosula S.
    Semin Nucl Med; 2011 Jul 18; 41(4):283-99. PubMed ID: 21624562
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease.
    Kadir A, Marutle A, Gonzalez D, Schöll M, Almkvist O, Mousavi M, Mustafiz T, Darreh-Shori T, Nennesmo I, Nordberg A.
    Brain; 2011 Jan 18; 134(Pt 1):301-17. PubMed ID: 21149866
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study.
    Rodriguez-Vieitez E, Ni R, Gulyás B, Tóth M, Häggkvist J, Halldin C, Voytenko L, Marutle A, Nordberg A.
    Eur J Nucl Med Mol Imaging; 2015 Jun 18; 42(7):1119-32. PubMed ID: 25893384
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.